[1]
“Treatment Patterns of Tocilizumab Utilization for Progressive Respiratory Distress during the COVID-19 Pandemic”, ijsmr, vol. 11, pp. 141–146, Nov. 2022, doi: 10.6000/1929-6029.2022.11.18.